课题基金 / 基金详情

T CELL DIFFERENTIATION

T CELL DIFFERENTIATION
T细胞分化
批准号:
6098945
负责人:
JEFFREY B FOWLKES
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

JEFFREY B FOWLKES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A major aim of this project is to identify the signals that control cell fate decisions in developing T cells. Our primary focus in the past year has been on the role of the T cell antigen receptor (TCR) and how it works together with other developmental cues to control maturation, proliferation, death, and lineage commitment. In these studies we have determined that: * The nature of the TCR signal (__ vs. __ in the _____ lineage choice and the involvement of CD4 vs. CD8 in the CD4/CD8 lineage decision) imposes a bias on the lineage choice. * Signals through the highly conserved, transmembrane receptor, Notch, also biases these lineage decisions. * A constitutively active form of Notch can override the bias normally imposed by the TCR signal, suggesting that the two signaling systems may act in concert to specify cell fate. * Cell-cell interactions between neighboring thymocytes influence __ versus __ T cell fate. * The expression of some TCR-associated signal transducing proteins are developmentally regulated in maturing T cells. * __ T cells require interactions with a self-protein, MHC, for maturation and survival (positive selection). If this interaction produces very strong signals inside the cell, cell death rather than maturation will occur (negative selection). Our results indicate that for those cells that survive, it is also the relative strength of the interaction that determines whether a cell will become a CD4 or CD8 T cell. * Once the lineage choice is made, additional mechanisms operate to insure that the appropriate T cell receptor is expressed in the appropriate lineage. * Whether a developing T cell is positively or negatively selected is affected by the quantity of MHC+peptide ligand and the cell type expressing the selecting ligand.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
3D Umbilical Venous Blood Flow - A New Paradigm for Improving the Assessment of Fetal Growth Restriction.
  • 批准号:
    10613412
  • 项目类别:
  • 资助金额:
    $59.45万
  • 财政年份:
    2019
  • 负责人:
    JEFFREY B FOWLKES
  • 依托单位:
3D Umbilical Venous Blood Flow - A New Paradigm for Improving the Assessment of Fetal Growth Restriction.
  • 批准号:
    10386856
  • 项目类别:
  • 资助金额:
    $60.83万
  • 财政年份:
    2019
  • 负责人:
    JEFFREY B FOWLKES
  • 依托单位:
Training Future Imaging Scientists for Biomedicine
Training Future Imaging Scientists for Biomedicine
海外基金